|
1
|
Huesker M, Folmer Y, Schneider M, Fulda C,
Blum HE and Hafkemeyer P: Reversal of drug resistance of
hepatocellular carcinoma cells by adenoviral delivery of anti-MDR1
ribozymes. Hepatology. 36:874–884. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nicolucci A: Epidemiological aspects of
neoplasms in diabetes. Acta Diabetol. 47:87–95. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Donadon V, Balbi M, Perciaccante A,
Casarin P and Zanette G: Insulin resistance and hyperinsulinemia in
patients with chronic liver disease and hepatocellular carcinoma.
Clin Med Insights Endocrinol Diabetes. 2:25–33. 2009.
|
|
4
|
Wang YG, Wang P, Wang B, Fu ZJ, Zhao WJ
and Yan SL: Diabetes mellitus and poorer prognosis in
hepatocellular carcinoma: A systematic review and meta-analysis.
PLoS One. 9:e954852014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeFronzo RA and Ferrannini E: Insulin
resistance. A multifaceted syndrome responsible for NIDDM, obesity,
hypertension, dyslipidemia, and atherosclerotic cardiovascular
disease. Diabetes Care. 14:173–194. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tsugane S and Inoue M: Insulin resistance
and cancer: Epidemiological evidence. Cancer Sci. 101:1073–1079.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Farrell G: Insulin resistance, obesity,
and liver cancer. Clin Gastroenterol Hepatol. 12:117–119. 2014.
View Article : Google Scholar
|
|
8
|
Leclercq IA, Da Silva Morais A, Schroyen
B, Van Hul N and Geerts A: Insulin resistance in hepatocytes and
sinusoidal liver cells: Mechanisms and consequences. J Hepatol.
47:142–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Feng YH, Lin CY, Huang WT, Wu CL, Fang JL
and Tsao CJ: Diabetes mellitus impairs the response to
intra-arterial chemotherapy in hepatocellular carcinoma. Med Oncol.
28:1080–1088. 2011. View Article : Google Scholar
|
|
10
|
Quan X, Wang J, Liang C, Zheng H and Zhang
L: Melatonin inhibits tunicamycin-induced endoplasmic reticulum
stress and insulin resistance in skeletal muscle cells. Biochem
Biophys Res Commun. 463:1102–1107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jong CJ, Ito T, Azuma J and Schaffer S:
Taurine depletion decreases GRP78 expression and downregulates
Perk-dependent activation of the unfolded protein response. Adv Exp
Med Biol. 803:571–579. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li LJ, Li GD, Wei HL, Chen J, Liu YM, Li
F, Xie B, Wang B and Li CL: Insulin resistance reduces sensitivity
to Cis-platinum and promotes adhesion, migration and invasion in
HepG2 cells. Asian Pac J Cancer Prev. 15:3123–3128. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Li G, Wei H, Sun J, Chen J, Xie B,
Wang B, Gu J, Li C, Tian B, et al: The endoplasmic reticulum stress
response is associated with insulin resistance-mediated drug
resistance in HepG2 cells. Neoplasma. 62:180–190. 2015. View Article : Google Scholar
|
|
14
|
Kurakula K, Hamers AA, van Loenen P and de
Vries CJ: 6-Mercaptopurine reduces cytokine and Muc5ac expression
involving inhibition of NFκB activation in airway epithelial cells.
Respir Res. 16:732015. View Article : Google Scholar
|
|
15
|
Li CL, Wei HL, Chen J, Wang B, Xie B, Fan
LL and Li LJ: Arsenic trioxide induces autophagy and antitumor
effects in Burkitt's lymphoma Raji cells. Oncol Rep. 32:1557–1563.
2014.PubMed/NCBI
|
|
16
|
Zhou G and Kuo MT: NF-kappaB-mediated
induction of mdr1b expression by insulin in rat hepatoma cells. J
Biol Chem. 272:15174–15183. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ledoux S, Yang R, Friedlander G and
Laouari D: Glucose depletion enhances P-glycoprotein expression in
hepatoma cells: Role of endoplasmic reticulum stress response.
Cancer Res. 63:7284–7290. 2003.PubMed/NCBI
|
|
18
|
Morand JP, Macri J and Adeli K: Proteomic
profiling of hepatic endoplasmic reticulum-associated proteins in
an animal model of insulin resistance and metabolic dyslipidemia. J
Biol Chem. 280:17626–17633. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Marrero JA, Kudo M and Bronowicki JP: The
challenge of prognosis and staging for hepatocellular carcinoma.
Oncologist. 15(Suppl 4): S23–S33. 2010. View Article : Google Scholar
|
|
20
|
Johnson PJ: Systemic chemotherapy of liver
tumors. Semin Surg Oncol. 19:116–124. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roberts LR: Sorafenib in liver cancer -
just the beginning. N Engl J Med. 359:420–422. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Nagaoki Y, Hyogo H, Aikata H, Tanaka M,
Naeshiro N, Nakahara T, Honda Y, Miyaki D, Kawaoka T, Takaki S, et
al: Recent trend of clinical features in patients with
hepatocellular carcinoma. Hepatol Res. 42:368–375. 2012. View Article : Google Scholar
|
|
24
|
Huo TI, Wu JC, Lui WY, Lee PC, Huang YH,
Chau GY, Tsay SH, Chang FY and Lee SD: Diabetes mellitus is a
recurrence-independent risk factor in patients with hepatitis B
virus-related hepatocellular carcinoma undergoing resection. Eur J
Gastroenterol Hepatol. 15:1203–1208. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Oki E, Baba H, Tokunaga E, Nakamura T,
Ueda N, Futatsugi M, Mashino K, Yamamoto M, Ikebe M, Kakeji Y, et
al: Akt phosphorylation associates with LOH of PTEN and leads to
chemoresistance for gastric cancer. Int J Cancer. 117:376–380.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kourelis TV and Siegel RD: Metformin and
cancer: New applications for an old drug. Med Oncol. 29:1314–1327.
2012. View Article : Google Scholar
|
|
27
|
Oliveras-Ferraros C, Cufí S,
Vazquez-Martin A, Menendez OJ, Bosch-Barrera J, Martin-Castillo B,
Joven J and Menendez JA: Metformin rescues cell surface major
histocompatibility complex class I (MHC-I) deficiency caused by
oncogenic transformation. Cell Cycle. 11:865–870. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shen Z, Ye Y, Bin L, Yin M, Yang X, Jiang
K and Wang S: Metabolic syndrome is an important factor for the
evolution of prognosis of colorectal cancer: Survival, recurrence,
and liver metastasis. Am J Surg. 200:59–63. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yoshiuchi K, Kaneto H, Matsuoka TA, Kohno
K, Iwawaki T, Nakatani Y, Yamasaki Y, Hori M and Matsuhisa M:
Direct monitoring of in vivo ER stress during the development of
insulin resistance with ER stress-activated indicator transgenic
mice. Biochem Biophys Res Commun. 366:545–550. 2008. View Article : Google Scholar
|
|
30
|
Misra UK and Pizzo SV: Up-regulation of
GRP78 and antiapoptotic signaling in murine peritoneal macrophages
exposed to insulin. J Leukoc Biol. 78:187–194. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kaneto H, Nakatani Y, Kawamori D,
Miyatsuka T, Matsuoka TA, Matsuhisa M and Yamasaki Y: Role of
oxidative stress, endoplasmic reticulum stress, and c-Jun
N-terminal kinase in pancreatic beta-cell dysfunction and insulin
resistance. Int J Biochem Cell Biol. 38:782–793. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Al-Rawashdeh FY, Scriven P, Cameron IC,
Vergani PV and Wyld L: Unfolded protein response activation
contributes to chemoresistance in hepatocellular carcinoma. Eur J
Gastroenterol Hepatol. 22:1099–1105. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lin JA, Fang SU, Su CL, Hsiao CJ, Chang
CC, Lin YF and Cheng CW: Silencing glucose-regulated protein 78
induced renal cell carcinoma cell line G1 cell-cycle arrest and
resistance to conventional chemotherapy. Urol Oncol.
32:29.e1–29.e11. 2014. View Article : Google Scholar
|
|
34
|
Nagelkerke A, Bussink J, van der Kogel AJ,
Sweep FC and Span PN: The PERK/ATF4/LAMP3-arm of the unfolded
protein response affects radioresistance by interfering with the
DNA damage response. Radiother Oncol. 108:415–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Atkins C, Liu Q, Minthorn E, Zhang SY,
Figueroa DJ, Moss K, Stanley TB, Sanders B, Goetz A, Gaul N, et al:
Characterization of a novel PERK kinase inhibitor with antitumor
and antiangiogenic activity. Cancer Res. 73:1993–2002. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang HY and Wek RC: Phosphorylation of
the α-subunit of the eukaryotic initiation factor-2 (eIF2α) reduces
protein synthesis and enhances apoptosis in response to proteasome
inhibition. J Biol Chem. 280:14189–14202. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Feng J, Chen X and Sun X, Wang F and Sun
X: Expression of endoplasmic reticulum stress markers GRP78 and
CHOP induced by oxidative stress in blue light-mediated damage of
A2E-containing retinal pigment epithelium cells. Ophthalmic Res.
52:224–233. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Gagliano T, Gentilin E, Benfini K, Di
Pasquale C, Tassinari M, Falletta S, Feo C, Tagliati F, Uberti ED
and Zatelli MC: Mitotane enhances doxorubicin cytotoxic activity by
inhibiting P-gp in human adrenocortical carcinoma cells. Endocrine.
47:943–951. 2014. View Article : Google Scholar : PubMed/NCBI
|
